MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dopaminergic neurons"

  • 2017 International Congress

    Inhibition of mitochondrial complex I synthesis by chloramphenicol mitigates dopaminergic neuronal cell loss in PQ-induced parkinsonism

    S.J. Kim, J. Han, Y. Jang, J. Kim, M.J. Lee, I. Ryu, X. Ju, M.J. Ryu, W. Chung, J.Y. Heo (Daejeon, Republic of Korea)

    Objective: To find the potent drug for prevention of PD, we screened with above 1000 drugs in the PQ treated cells which currently used drug…
  • 2017 International Congress

    Neural correlates of movement sequence kinematics in substantia nigra dopaminergic cells

    M. Mendonça, J. Alves Silva, L. Hernandez, J. Obeso, R. Costa (Lisboa, Portugal)

    Objective: To develop a new behavioral task for assessment of mice forelimb movements, and evaluate the substantia nigra pars compacta dopaminergic cells’ (SNpc) correlates of…
  • 2017 International Congress

    Admixing augments nigral dopaminergic correlates during development to impart resistance to MPTP-toxicity at adulthood

    V. D J, Y. H, R. T R, P. Anand Alladi (Bangalore, India)

    Objective: Establish the developmental basis for varying nigral dopaminergic (DA) correlates in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) susceptible C57BL/6, MPTP resistant CD-1 and their resistant crossbred mice. Background:…
  • 2017 International Congress

    Efficient control of dopamine neuron physiology for rescuing disease phenotypes

    T. Rumbell, J. Kozloski (Yorktown Heights, NY, USA)

    Objective: Dopamine neurons (DAs) of the substantia nigra degenerate in Parkinson's disease and are disrupted in Huntington's disease. Here we propose single cell computational modeling…
  • 2017 International Congress

    Striatal dopamine transporter abnormalities in pure autonomic failure and speculation about the relationship with Lewy bodies

    M. Yogo, M. Morita, M. Suzuki (Tokyo, Japan)

    Objective: To reveal dopamine transporter (DAT) abnormalities in pure autonomic failure (PAF) and speculate about the relationship with the Lewy body progression pathway.    Background:…
  • 2017 International Congress

    Piper betle L. Attenuates 6-OHDA Induced Apoptosis in SH-SY5Y Cells and Neuronal Injury in Caenorhabditis elegans Parkinson’s Model

    G. Shanmugam, A. Mohankumar, P. Sundararaj (Coimbatore, India)

    Objective: To explore the anti-apoptotic effects of Piper bitle leaf extract (PLE) on 6-OHDA induced cellular injury in human neuroblastoma cell SH-SY5Y. To analyse the neuroprotective…
  • 2017 International Congress

    Role of Apocyanin in modulating glial cell functions and associated inflammatory response in Lipopolysaccharide induced Parkinson’s disease model.

    N. Sharma, B. Nehru (Chandigarh, India)

    Objective: To explore the effect of apocyanin on glia mediated inflammatory response and α-synuclein aggregation in single intranigral LPS induced PD model Background: Converging lines…
  • 2017 International Congress

    Rotenone induces astrocyte-mediated non-cell autonomous dopaminergic neurotoxicity

    I. Miyazaki, S. Murakami, R. Kikuoka, N. Isooka, Y. Kitamura, M. Asanuma (Okayama, Japan)

    Objective: In this study, we examined involvement of astrocytes in rotenone-induced dopaminergic neurotoxicity using primary cultured cells. Background: Several studies reported that pesticide exposure, such…
  • 2017 International Congress

    Curcumin I prevents the developmental defective sensorimotor patterns resulted from Lead poisoning in rat

    H. BENAMMI, O. EL HIBA, H. GAMRANI (Marrakech, Morocco)

    Objective: In the present investigation, we evaluated the effect of prenatal exposure of rats to lead from neonatal to adult age on the sensorimotor performances…
  • 2017 International Congress

    Patient-derived GBA1-PARK2 double-mutant cellular models to study the effect of GBA1 as a modifier of familial Parkinson’s disease

    Z. Hanss, I. Boussaad, P. Barbuti, S. Goldwurm, R. Krüger (Belvaux, Luxembourg)

    Objective: In this study, we propose to decipher the role of GBA1 as a modifier of familial Parkinson’s disease (PD) using double-mutant patient-derived cellular models…
  • « Previous Page
  • 1
  • …
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley